# DESTINATION 2 (NCT06638541)

> Dose dE-eScalaTion IN prostATe radIOtherapy usiNg an MR-Linac in 2 Fractions

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT06638541
- Phase: NA
- Status: RECRUITING
- Sponsor: Royal Marsden NHS Foundation Trust
- Conditions: Prostate Cancer
- Interventions: Prostate radical radiotherapy
- Enrollment: 54
- Primary outcome: Acute GU toxicity

## Preliminary discovery

Commentary in our index that names this trial so far. Final coverage is set when the report is built.

- X threads: 10
- Podcasts: 1

## Order

Standard, $1,250, price fixed at order: https://www.erudio.com/contact?report=destination-2-nct06638541

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT06638541", "email": "<work email>"}; the inbox owner confirms by the emailed link.